1) Gold MR, et al:Cost-effectiveness in Health and Medicine. Oxford University Press, New York, 1996
ed). Oxford University Press, New York, 1997
3) Drummond MF, et al:Economic evaluation in health care. Merging theory with practice. Oxford University Press, New York, 2001
4) Boardman AE, et al:Cost-Benefit Analysis;Concepts and Practice. Prentice Hall, Upper Saddle River, 1996
5) Neville AM, et al:An alternative cost effectiveness analysis of ThinPrep in the Australian setting. Aust N Z J Obstet Gynaecol 45(4):289-294, 2005
6) Shen Y, et al:A model-based comparison of breast cancer screening strategies;Mammograms and clinical breast examinations. Cancer Epidemiol Biomarkers Prev 14(2):529-532, 2005
7) Pignone M, et al:Cost-effectiveness analyses of colorectal cancer screening;A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137:96-104, 2002
8) Pauly MV: Valuing health care benefits in money terms. Sloan FA (ed):Valuing Health Care;Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies. Cambridge University Press, Cambridge, 1995
9) Clarke PM:Cost-benefit analysis and mammographic screening;A travel cost approach. J Health Econ 17(6):767-787, 1998
10) Ohshige K, et al:Willingness to pay for a public health checkup program;Assessment by the travel cost method. Jpn J Public Health 51(11):938-944, 2004
11) 研究班報告書:平成17年度厚生労働科学研究費補助金厚生労働科学特別研究事業「がん検診の経済的効果及び制度のあり方に関する研究」(主任研究者:水嶋春朔)総括・分担研究報告書,2006
12) 漆博雄(編):医療経済学.東京大学出版,1998
rded). Prentice-Hall, New Jersey, 2001
14) 遠藤久夫:マネジドケアの基本特性とその功罪.医療と社会8:7-19, 1993
15) 川渕孝一:米国におけるマネジドケアの現状と課題.医療と社会8:53-71, 1993
16) The Office of the Patient Advocate http://www.opa.ca.gov
17) Keiser Parmanente http://www.kaiserpermanente.org/
18) Health Net Inc https://www.healthnet.com/portal/member/home.do
19) U.S. Preventive Services Task Force(USPSTF) http://www.ahrq.gov/clinic/uspstfix.htm
20) American Cancer Society http://www.cancer.org/docroot/home/